Clinical Trials Directory

Trials / Completed

CompletedNCT00042926

Diagnostic Trial in Patients Who Are Undergoing Surgery for Early Stage Mouth Cancer

A Trial Of Lymphatic Mapping And Sentinel Node Lymphadenectomy For Patients With T1 or T2 Clinically N0 Oral Cavity Squamous Cell Carcinoma

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
161 (actual)
Sponsor
Alliance for Clinical Trials in Oncology · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

RATIONALE: Diagnostic procedures to detect cancer cells in sentinel lymph nodes may help plan effective cancer treatment. PURPOSE: Diagnostic trial to study the effectiveness of lymph node mapping and sentinel lymph node lymphadenectomy in patients who are undergoing surgery to remove early-stage cancer of the mouth.

Detailed description

OBJECTIVES: * Determine whether a negative hematoxylin and eosin finding from the lymphatic mapping and sentinel node lymphadenectomy procedure accurately predicts the negativity of the other cervical lymph nodes in patients with stage I or II squamous cell carcinoma of the oral cavity. * Determine the extent and pattern of disease spread in the nodal bed in these patients. * Obtain data on the use of immunohistochemistry to assess nodes in these patients.

Conditions

Interventions

TypeNameDescription
OTHERimmunohistochemistry staining method
PROCEDUREconventional surgery
PROCEDURElymphangiography
PROCEDUREradionuclide imaging
PROCEDUREsentinel lymph node biopsy
RADIATIONtechnetium Tc 99m sulfur colloid

Timeline

Start date
2002-05-01
Primary completion
2007-05-01
Completion
2010-11-01
First posted
2003-01-27
Last updated
2016-12-07

Source: ClinicalTrials.gov record NCT00042926. Inclusion in this directory is not an endorsement.

Diagnostic Trial in Patients Who Are Undergoing Surgery for Early Stage Mouth Cancer (NCT00042926) · Clinical Trials Directory